SNDX Stock-Based Compensation
Syndax Pharmaceuticals Inc · Stock-Based Compensation
SNDX Stock-Based Compensation
Latest reported$49.40Mperiod ending
SNDX Stock-Based Comp ($0.00 → $49.40M)
Annual stock-based compensation
High-resolution chart · PNG
SNDX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 47,503,000 | |
| 43,026,000 | |
| 30,951,000 | |
| 16,019,000 | |
| 13,317,000 | |
| 9,057,000 | |
| 6,005,000 | |
| 6,201,000 | |
| 5,450,000 | |
| 4,708,000 | |
| 3,882,000 | |
| 2,257,000 | |
| 1,415,000 | |
| 139,000 | |
| 0 |